ASF Research Director, Dr. André Weinstock, provides a 3-minute update on the state of Alport research and how community contributions are helping the development of Alport syndrome therapies. See below for resources discussed in the video.
The new ASF landing page for Researchers and Pharma Companies: [ Ссылка ]
ASF Alport Patient Registry:
[ Ссылка ]
The NEPTUNE Alport Cohort Study [Please note that this study is now filled and no longer recruiting]:
[ Ссылка ]
Kashtan CE, Ding J, Garosi G, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018 May;93(5):1045-1051. doi: 10.1016/j.kint.2017.12.018 [ Ссылка ]30085-1/fulltext
Feldman DL, Vachon G, Kashtan CE, et al. Voice of the Patient: Report on the Externally Led Patient-Focused Drug Development Meeting on Alport Syndrome. 2019. Accessed July 16, 2024. [ Ссылка ]
Weinstock BA, Feldman DL, Fornoni A, et al. Clinical trial recommendations for potential Alport syndrome therapies. Kidney Int. 2020 Jun;97(6):1109-1116. doi: 10.1016/j.kint.2020.02.029 [ Ссылка ]30352-5/fulltext
